These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 22676126)

  • 21. Transforming growth factor type e is a novel mediator of wound repair.
    Carter BJ; Halper J
    Wound Repair Regen; 1996; 4(2):259-68. PubMed ID: 17177823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of endogenous transforming growth factor-beta and its type I and type II receptors in rat burn wounds.
    Wei D; Ge S; Chen Y; Dai F; Su B
    Wound Repair Regen; 1997; 5(3):229-34. PubMed ID: 16984436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue expression of transforming growth factor-beta1 and transforming growth factor-alpha during wound healing in human skin explants.
    Kratz G; Compton CC
    Wound Repair Regen; 1997; 5(3):222-8. PubMed ID: 16984435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta activity is increased in peritoneal fluid from women with endometriosis.
    Oosterlynck DJ; Meuleman C; Waer M; Koninckx PR
    Obstet Gynecol; 1994 Feb; 83(2):287-92. PubMed ID: 8290196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines.
    Cooper CS; Blair DG; Oskarsson MK; Tainsky MA; Eader LA; Vande Woude GF
    Cancer Res; 1984 Jan; 44(1):1-10. PubMed ID: 6418375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of epidermal growth factor and transforming growth factors in mammary development and lactation.
    Plaut K
    J Dairy Sci; 1993 Jun; 76(6):1526-38. PubMed ID: 8326026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor beta-1 modulates the number of beta-adrenergic receptors in cardiac fibroblasts.
    Iizuka K; Sano H; Kawaguchi H; Kitabatake A
    J Mol Cell Cardiol; 1994 Apr; 26(4):435-40. PubMed ID: 8072001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of binding of transforming growth factor-beta 1 to bovine mammary membranes.
    Plaut K; Maple RL
    J Dairy Sci; 1995 Jul; 78(7):1463-9. PubMed ID: 7593839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over expression of transforming growth factor-alpha and epidermal growth factor receptor in human hepatic cirrhosis tissues.
    Qiao Q; Zhang J; Wang W; Li Q
    Hepatogastroenterology; 2008; 55(81):169-72. PubMed ID: 18507100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of agarose culture to measure the effect of transforming growth factor beta and epidermal growth factor on rabbit articular chondrocytes.
    Skantze KA; Brinckerhoff CE; Collier JP
    Cancer Res; 1985 Sep; 45(9):4416-21. PubMed ID: 2992779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autocrine transforming growth factor-beta(1) activity and glycosaminoglycan synthesis by human cutaneous scar fibroblasts.
    Messadi DV; Berg S; Sung-Cho K; Lesavoy M; Bertolami CN
    Wound Repair Regen; 1994 Oct; 2(4):284-91. PubMed ID: 17147647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of biological activity of linear alpha-transforming growth factor and monospecific antibodies to alpha-transforming growth factor and linear alpha-transforming growth factor.
    Hanauske AR; Buchok JB; Pardue RL; Muggia VA; Von Hoff DD
    Cancer Res; 1986 Nov; 46(11):5567-70. PubMed ID: 3463415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between H-ras p21TLeu61 protein content and tumorigenicity of NIH3T3 cells.
    Bizub D; Blair D; Alvord G; Skalka AM
    Oncogene; 1988 Oct; 3(4):443-8. PubMed ID: 3078952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK; Lynch KE; Podolsky DK
    Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
    Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM
    Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding and internalization of transforming growth factor-beta 1 by human hepatoma cells: evidence for receptor recycling.
    Sathre KA; Tsang ML; Weatherbee JA; Steer CJ
    Hepatology; 1991 Aug; 14(2):287-95. PubMed ID: 1650327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of hepatocyte growth factor, transforming growth factor-alpha and transforming growth factor-beta 1 messenger RNAs in two experimental models of liver cell proliferation.
    Masuhara M; Katyal SL; Nakamura T; Shinozuka H
    Hepatology; 1992 Nov; 16(5):1241-9. PubMed ID: 1427663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of transforming growth factor-alpha on airway angiogenesis.
    Schraufnagel DE; Arzouman DA; Sekosan M; Ho YK
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1582-8. PubMed ID: 1280750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming industry.
    Hirschhorn JS
    Environ Sci Technol; 1995 Aug; 29(8):377A. PubMed ID: 22676126
    [No Abstract]   [Full Text] [Related]  

  • 40. [Technological evolution in the manufacting industry].
    Settineri L
    G Ital Med Lav Ergon; 2011; 33(3):234-8. PubMed ID: 22073666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.